In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biocompatibles International PLC

Division of Boston Scientific Corp.
www.biocompatibles.com

Latest From Biocompatibles International PLC

Boston Scientific's Drive To Add To Core Strength Continues With BTG Buy

When Boston Scientific chief medical officer Ian Meredith spoke in mid-2018 of the group's appetite for core M&A, there was a sense that more strategic moves were likely before the year was out. The inference was right, and a busy year for Boston Scientific got much busier when it made a cash offer for UK interventional medicine specialist BTG PLC. The bid values the target company at £4.28 billion, and completion is expected by mid-2019.

M & A Cancer

Boston Scientific Agrees To Pay $4.2Bn For UK Interventional Oncology Firm BTG

A busy year of M&A for Boston Scientific just got busier with a $4.2bn cash offer for UK interventional medicine specialist BTG. Completion is expected by mid-year 2019.

M & A Business Strategies

BTG Set To Launch First Radiopaque Drug-Eluting Bead In The EU

DC Bead Lumi is designed to be loaded with doxorubicin or irinotecan to treat liver cancer while showing the treating physician where it is to improve control of transarterial chemoembolization procedures.

Cancer Innovation

BTG Deals Its Way Into Interventional Medicine

UK-listed BTG PLC is on a route to a major future in interventional medicine, having built solid foundations in licensing and specialty pharma. CEO Louise Makin describes the deal- and decision-making rationale that has allowed a mid-cap player to set billion-dollar plus ambitions in interventional medicine, based on organic and M&A growth.

Business Strategies M & A
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Boston Scientific Corp.
  • Senior Management
  • Crispin Simon, CEO
    Ian Ardill, Dir., Fin.
    Mike Motion, Dir., Sales & Mktg.
  • Contact Info
  • Biocompatibles International PLC
    Phone: (44) 1252 732 732
    Chapman House, Farnham Bus. Park.
    Weydon Ln.
    Farnham, GU9 8QL
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register